Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue

被引:4
作者
Chalmers C.R. [1 ]
Fenwick S.W. [1 ]
Toogood G.J. [2 ]
Hull M.A. [1 ]
机构
[1] Section of Molecular Gastroenterology, University of Leeds, St. James's University Hospital
[2] Department of Hepatobiliary Surgery, St. James's University Hospital
基金
英国医学研究理事会;
关键词
Angiogenesis; Apoptosis; Cyclooxygenase-2; Endothelial cell; Immunohistochemistry; Microvessel density; Proliferation;
D O I
10.1007/s10456-006-9050-0
中图分类号
学科分类号
摘要
There is a need for simple, reproducible methodology for measurement of endothelial cell (EC) apoptosis and proliferation in formalin-fixed, paraffin-embedded (FFPE) human tissue obtained in clinical trials of potential anti-angiogenic agents. Therefore, we developed colorimetric, dual-label immunohistochemical techniques for use on FFPE tissue, based on the use of single-stranded (ss) DNA and Ki-67 as markers of EC apoptosis and proliferation, respectively. Digital image analysis was used to obtain the total tumour microvessel density (MVD), from which the EC apoptosis index (AI) and proliferation index (PI) were derived manually as the number of positive ECs per vessel. Immunohistochemical measurement of EC apoptosis and proliferation was validated on human colorectal cancer liver metastases from a randomized, placebo-controlled trial of the selective cyclooxygenase-2 inhibitor rofecoxib. Proliferating and apoptotic ECs clustered in discrete areas of the tumour vasculature. ECAI (median [inter-quartile range, IQR] 0.0018 [0.0003-0.0064]) and ECPI (median [IQR] 0.0043 [0.002-0.014]) values were low and highly variable in tumours from both placebo- and rofecoxib-treated patients. Our novel dual-label immunohistochemical methods will be generally applicable in FFPE human cancer tissue and should prove invaluable for measuring the anti-angiogenic activity of experimental therapies in clinical trials. The low absolute level of and variability in EC apoptosis and proliferation detectable in human colorectal cancer liver metastases indicates that similar intervention studies using these end-points will need to ensure adequate size in order to be able to detect anti-angiogenic activity by immunohistochemical methods. © 2006 Springer Science + Business Media B.V.
引用
收藏
页码:193 / 200
页数:7
相关论文
共 17 条
  • [1] Folkman J., Browder T., Palmblad J., Angiogenesis research: Guidelines for translation to clinical application, Thromb Haemost, 86, pp. 23-33, (2001)
  • [2] Hlatky L., Hahnfeldt P., Folkman J., Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us, J Natl Cancer Inst, 94, pp. 883-893, (2002)
  • [3] Herbst R.S., Mullani N.A., Davis D.W., Et al., Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin, J Clin Oncol, 20, pp. 3804-3814, (2002)
  • [4] Davis D.W., Takamori R., Raut C.P., Et al., Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668, Clin Cancer Res, 11, pp. 678-689, (2005)
  • [5] Fenwick S.W., Toogood G.J., Lodge J.P., Hull M.A., The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases, Gastroenterology, 125, pp. 716-729, (2003)
  • [6] Chalmers C.R., Wilson D.J., Ward J., Robinson P.J., Toogood G.J., Hull M.A., Anti-angiogenic activity of the selective cyclooxygenase-2 inhibitor rofecoxib in human colorectal cancer liver metastases, Gut, 55, pp. 1058-1059, (2006)
  • [7] Frankfurt O.S., Krishan A., Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin, J Histochem Cytochem, 49, pp. 369-378, (2001)
  • [8] Watanabe I., Toyoda M., Okuda J., Et al., Detection of apoptotic cells in human colorectal cancer by two different in situ methods: Antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) methods, Jpn J Cancer Res, 90, pp. 188-193, (1999)
  • [9] Edgell C.J., McDonald C.C., Graham J.B., Permanent cell line expressing human factor VIII-related antigen established by hybridization, Proc Natl Acad Sci USA, 80, pp. 3734-3737, (1983)
  • [10] Vermeulen P.B., Verhoeven D., Hubens G., Et al., Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas, Ann Oncol, 6, pp. 59-64, (1995)